Clinical Trial Update: Cell Cycle Regulatory Gene Study in Patients With Myeloproliferative Disorders

View source ↗

Summary

A clinical trial (NCT02663648) evaluating a cell cycle regulatory gene study in myeloproliferative neoplasms has been withdrawn by the sponsor, Shandong Univers…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia
• Essential Thrombocythemia
• Myelofibrosis
• Myeloproliferative Neoplasms
• Polycythemia Vera

Snippet

Sponsor: Shandong University | Conditions: Myeloproliferative Disorders, Polycythemia Vera | Status: WITHDRAWN